BIXT
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
8.9M
BSEM
Price
$11.94
Change
-$0.05 (-0.42%)
Updated
Jul 3 closing price
Capitalization
199.31M
50 days until earnings call
Interact to see
Advertisement

BIXT vs BSEM

Header iconBIXT vs BSEM Comparison
Open Charts BIXT vs BSEMBanner chart's image
Bioxytran
Price$0.10
Change-$0.00 (-0.00%)
Volume$21.09K
Capitalization8.9M
BioStem Technologies
Price$11.94
Change-$0.05 (-0.42%)
Volume$28.03K
Capitalization199.31M
BIXT vs BSEM Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. BSEM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and BSEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BIXT: $0.10 vs. BSEM: $11.94)
Brand notoriety: BIXT and BSEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 14% vs. BSEM: 50%
Market capitalization -- BIXT: $8.9M vs. BSEM: $199.31M
BIXT [@Biotechnology] is valued at $8.9M. BSEM’s [@Biotechnology] market capitalization is $199.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 1 FA rating(s) are green whileBSEM’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 1 green, 4 red.
  • BSEM’s FA Score: 0 green, 5 red.
According to our system of comparison, BSEM is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 2 TA indicator(s) are bullish while BSEM’s TA Score has 2 bullish TA indicator(s).

  • BIXT’s TA Score: 2 bullish, 5 bearish.
  • BSEM’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than BSEM.

Price Growth

BIXT (@Biotechnology) experienced а -10.63% price change this week, while BSEM (@Biotechnology) price change was -10.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BSEM is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSEM($199M) has a higher market cap than BIXT($8.9M). BIXT has higher P/E ratio than BSEM: BIXT (40.65) vs BSEM (8.12). BIXT YTD gains are higher at: 11.235 vs. BSEM (-13.728). BSEM has more cash in the bank: 110K vs. BIXT (4.35K). BIXT has less debt than BSEM: BIXT (1.26M) vs BSEM (6.02M).
BIXTBSEMBIXT / BSEM
Capitalization8.9M199M4%
EBITDA-2.38MN/A-
Gain YTD11.235-13.728-82%
P/E Ratio40.658.12500%
Revenue0N/A-
Total Cash4.35K110K4%
Total Debt1.26M6.02M21%
FUNDAMENTALS RATINGS
BIXT vs BSEM: Fundamental Ratings
BIXT
BSEM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6349
P/E GROWTH RATING
1..100
10070
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (1) in the null industry is somewhat better than the same rating for BSEM (56). This means that BIXT’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for BIXT (100). This means that BSEM’s stock grew somewhat faster than BIXT’s over the last 12 months.

BSEM's SMR Rating (100) in the null industry is in the same range as BIXT (100). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

BSEM's Price Growth Rating (49) in the null industry is in the same range as BIXT (63). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

BSEM's P/E Growth Rating (70) in the null industry is in the same range as BIXT (100). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTBSEM
RSI
ODDS (%)
Bullish Trend 5 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
76%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGCX43.020.38
+0.89%
MFS Core Equity C
GLOSX22.450.15
+0.67%
Victory Pioneer Global Equity A
GLPIX37.910.04
+0.11%
Goldman Sachs MLP Energy Infras Inv
IGNYX17.30-0.02
-0.12%
Macquarie Natural Resources Y
HNRGX28.34-0.05
-0.18%
Hennessy Energy Transition Investor

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+1.88%
CING - BIXT
26%
Poorly correlated
-1.38%
CYTK - BIXT
22%
Poorly correlated
+0.87%
APLM - BIXT
21%
Poorly correlated
-6.40%
ANEB - BIXT
20%
Poorly correlated
-7.18%
TTNP - BIXT
20%
Poorly correlated
+1.15%
More

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VICP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VICP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
-0.42%
VICP - BSEM
23%
Poorly correlated
N/A
BMNDF - BSEM
11%
Poorly correlated
N/A
BVNRY - BSEM
9%
Poorly correlated
+0.11%
BIXT - BSEM
6%
Poorly correlated
+1.88%
CMVLF - BSEM
5%
Poorly correlated
N/A
More